1. Editorial: good news to patients with thalassaemia—HCV clearance made easy with direct acting antivirals. Authors' reply. Issue 6 (14th August 2017) Authors: Mangia, A.; Piazzolla, V.; Santoro, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 6(2017) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Editorial: good news to patients with thalassaemia—HCV clearance made easy with direct acting antivirals. Authors' reply. Issue 6 (September 2017) Authors: Mangia, A.; Piazzolla, V.; Santoro, R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 6(2017) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomised clinical trial: sofosbuvir and ledipasvir in patients with transfusion‐dependent thalassaemia and HCV genotype 1 or 4 infection. Issue 4 (29th June 2017) Authors: Mangia, A.; Sarli, R.; Gamberini, R.; Piga, A.; Cenderello, G.; Piazzolla, V.; Santoro, R.; Caruso, V.; Quarta, A.; Ganga, R.; Copetti, M.; Forni, G. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 4(2017) Page Start: 424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗